DNA-methylation of the homeodomain transcription factor PITX2 reliably predicts risk of distant disease recurrence in tamoxifen-treated, node-negative breast cancer patients--Technical and clinical validation in a multi-centre setting in collaboration with the European Organisation for Research and

[1]  M. Frühwald.  DNA Methylation Patterns in Cancer , 2012 .

[2]  R. Gelber,et al.  Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005. , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

[3]  John W M Martens,et al.  Association of DNA methylation of phosphoserine aminotransferase with response to endocrine therapy in patients with recurrent breast cancer. , 2005, Cancer research.

[4]  Y Wang,et al.  Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials , 2005, The Lancet.

[5]  J. Foekens,et al.  Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer , 2005, The Lancet.

[6]  K. Schiffman,et al.  Endogenous anti-HER2 antibodies block HER2 phosphorylation and signaling through extracellular signal-regulated kinase. , 2005, Cancer research.

[7]  M. Cronin,et al.  A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. , 2004, The New England journal of medicine.

[8]  J. Herman,et al.  Gene silencing in cancer in association with promoter hypermethylation. , 2003, The New England journal of medicine.

[9]  Huidong Shi,et al.  The androgen receptor gene is preferentially hypermethylated in follicular non-Hodgkin's lymphomas. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[10]  C. Tiffoche,et al.  Regulation of the intronic promoter of rat estrogen receptor alpha gene, responsible for truncated estrogen receptor product-1 expression. , 2003, Endocrinology.

[11]  J. Herman,et al.  Specific Inhibition of DNMT1 by Antisense Oligonucleotides Induces Re-expression of Estrogen Receptor a (ER) in ER-negative Human Breast Cancer Cell Lines , 2003, Cancer biology & therapy.

[12]  R. Dahiya,et al.  Hypermethylation can selectively silence multiple promoters of steroid receptors in cancers , 2003, Molecular and Cellular Endocrinology.

[13]  P. Laird.  Early detection: The power and the promise of DNA methylation markers , 2003, Nature Reviews Cancer.

[14]  Paola Briata,et al.  Identification of a Wnt/Dvl/β-Catenin → Pitx2 Pathway Mediating Cell-Type-Specific Proliferation during Development , 2002, Cell.

[15]  James N Ingle,et al.  American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  Marie Guillet,et al.  Regulation of prolactin, GH, and Pit-1 gene expression in anterior pituitary by Pitx2: An approach using Pitx2 mutants. , 2002, Endocrinology.

[17]  Thomas D. Otto,et al.  Tumour class prediction and discovery by microarray-based DNA methylation analysis , 2002 .

[18]  Yudong D. He,et al.  Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.

[19]  M. Toyota,et al.  Methylation profiling in acute myeloid leukemia. , 2001, Blood.

[20]  J. Herman,et al.  A gene hypermethylation profile of human cancer. , 2001, Cancer research.

[21]  Frank E. Harrell,et al.  Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis , 2001 .

[22]  Scar,et al.  Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. , 2000, The New England journal of medicine.

[23]  J. Herman,et al.  Aberrant methylation of the estrogen receptor and E-cadherin 5' CpG islands increases with malignant progression in human breast cancer. , 2000, Cancer research.

[24]  J. Herman,et al.  DNA hypermethylation in tumorigenesis: epigenetics joins genetics. , 2000, Trends in genetics : TIG.

[25]  D. Figarella-Branger,et al.  Expression of the members of the Ptx family of transcription factors in human pituitary adenomas. , 1999, The Journal of clinical endocrinology and metabolism.

[26]  C. Tabin,et al.  The Transcription Factor Pitx2 Mediates Situs-Specific Morphogenesis in Response to Left-Right Asymmetric Signals , 1998, Cell.

[27]  J. Carey,et al.  Cloning and characterization of a novel bicoid-related homeobox transcription factor gene, RIEG, involved in Rieger syndrome , 1996, Nature Genetics.

[28]  S. Martinez,et al.  Otlx2,anOtx-Related Homeobox Gene Expressed in the Pituitary Gland and in a Restricted Pattern in the Forebrain , 1996, Molecular and Cellular Neuroscience.

[29]  P. Jones,et al.  DNA methylation errors and cancer. , 1996, Cancer research.

[30]  D. Cox,et al.  Analysis of Survival Data. , 1985 .

[31]  W. Kraybill,et al.  The use of antiestrogens tamoxifen and nafoxidine in the treatment of human breast cancer in correlation with estrogen receptor values. A phase II study , 1978, Cancer.

[32]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[33]  G. Liang,et al.  Relationship between transcription and DNA methylation. , 2000, Current topics in microbiology and immunology.

[34]  E. Stone,et al.  Autosomal dominant iris hypoplasia is caused by a mutation in the Rieger syndrome (RIEG/PITX2) gene. , 1998, American journal of ophthalmology.